Company Filing History:
1 out of 3 
1 out of 2 
1 out of 1 Years Active: 2017
Title: Krystian Stodus: Innovator in Cancer Treatment
Introduction
Krystian Stodus is a notable inventor based in Warsaw, Poland. He has made significant contributions to the field of cancer treatment through his innovative research and patented methods. His work focuses on the development of therapeutic agents that target specific cancer mutations.
Latest Patents
Stodus holds a patent for a "Method for selection of hDIS3 PIN domain inhibitors and use of hDIS3 PIN domain inhibitors for cancer treatment." This invention relates to a method for screening hDIS3 PIN domain inhibitors, as well as the yeast strain and cell line used in such methods. The patent also discusses new therapeutic agents selected as hDIS3 PIN domain inhibitors and their applications in treating cancers with mutations in the hDIS3 RNB domain, particularly multiple myeloma. Additionally, the invention includes a composition comprising the new therapeutic agent and a method for inducing synthetic lethality in cancer cells.
Career Highlights
Throughout his career, Krystian Stodus has worked with esteemed organizations such as the Institute of Biochemistry and Biophysics of the Polish Academy of Sciences and Oncoarendi Therapeutics Sp. z o.o. His research has been pivotal in advancing the understanding of cancer treatment methodologies.
Collaborations
Stodus has collaborated with notable colleagues, including Andrzej Dziembowski and Rafal Tomecki. Their combined expertise has contributed to the success of his research initiatives.
Conclusion
Krystian Stodus is a prominent figure in the field of cancer research, with a focus on innovative therapeutic methods. His patented work has the potential to significantly impact cancer treatment strategies.